1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. EDITAS MEDICINE INC
Editas Medicine Inc XNAS: EDIT

Editas Medicine Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform ba...

Read More
2.09 -0.04 (-1.88%)
53.96% Fall from 52W High
1.3M
XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
13.0 / 100
Momentum Score
Technically Neutral
41.4 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
5
1Yr Price target upside is 145%
8 analysts

10

S

14

W

6

O

0

T

SWOT Analysis

Editas Medicine Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..